Documents
Application Sponsors
Marketing Status
Application Products
001 | SOLUTION;IONTOPHORESIS, TOPICAL | 0.01MG/ML;2% | 0 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE |
FDA Submissions
TYPE 4; Type 4 - New Combination | ORIG | 1 | AP | 2004-10-26 | STANDARD |
Submissions Property Types
CDER Filings
EMPI
cder:Array
(
[0] => Array
(
[ApplNo] => 21486
[companyName] => EMPI
[docInserts] => ["",""]
[products] => [{"drugName":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE","activeIngredients":"EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","strength":"0.01MG\/ML;2%","dosageForm":"SOLUTION;IONTOPHORESIS, TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/26\/2004","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/21486lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE","submission":"EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","actionType":"0.01MG\/ML;2%","submissionClassification":"SOLUTION;IONTOPHORESIS, TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2004-10-26
)
)